Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 10—October 2006
Research

Active Surveillance of Candidemia, Australia

Sharon Chen*Comments to Author , Monica Slavin†, Quoc Nguyen‡, Deborah Marriott‡, E. Geoffrey Playford§, David Ellis¶, Tania C. Sorrell*#, and the Australian Candidemia Study
Author affiliations: *Westmead Hospital, Westmead, New South Wales, Australia; †Royal Melbourne Hospital, Melbourne, Victoria, Australia; ‡St. Vincent's Hospital, Sydney, New South Wales, Australia; §Princess Alexandra Hospital, Brisbane, Queensland, Australia; ¶Women's and Children's Hospital, Adelaide, South Australia, Australia; #University of Sydney, Sydney, New South Wales, Australia

Main Article

Table 4

Multivariate predictors of death by candidemia 30 days after diagnosis, Australia, 2001–2004*

Characteristic OR 95% CI p value
Age >65 y 3.0 2.0–4.3 <0.001
ICU stay 3.2 2.1–5.0 <0.001
Corticosteroid therapy 2.8 1.9–4.1 <0.001
Hemodialysis 2.4 1.4–4.1 0.002
Hyperalimentation 1.7 1.1–2.5 0.006
Antimicrobial drug use 2.1 0.9–4.4 0.07
Neutropenia 2.2 1.3–3.6 0.002
Sepsis present 3.1 1.7–5.4 <0.001
Treatment with antifungal agent 0.01 0.06–0.2 <0.001
Candida glabrata infection 1.8 1.1–2.9 0.01

*Sixteen candidate variables were included in the final model. OR, odds ratio; CI, confidence interval; ICU, intensive care unit.

Main Article

Page created: November 10, 2011
Page updated: November 10, 2011
Page reviewed: November 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external